|
|
Application value of sentinel lymph node biopsy in axillary lymph node dissection of radical mastectomy |
QIU Yan-ping LI Yi-peng LIN Wen |
Maternity and Child Health Care Hospital of Heyuan City in Guangdong Procvince,Heyuan 517000,China |
|
|
Abstract ObjectiveTo explore the application value of sentinel lymph node biopsy (SLNB)in axillary lymph node dissection (ALND)of radical mastectomy.Methods50 patients with breast cancer in our hospital from April 2012 to April 2016 were selected as the study subjects and were treated with selective radical mastectomy.The patients were divided into the observation group and the control group according to whether undergoing SLNB,25 cases in each group. The observation group was given SLNB,and the control group was treated with ALND.According to the clinical pathological results,the sensitivity,specificity,accuracy and false negative rate of SLNB in predicting axillary lymph node metastasis were evaluated.Six months after operation,the outer diameters of midpoint(MP)of upper arm at affected side and uninjured side,the change rate of perimeter at 15 cm above the olecranon (C-15)were compared between the two groups.The quality of life was evaluated by quality of life(QOL)scale,and the incidence rates of complications in 1 year after operation was recorded.ResultsThe sensitivity,specificity,accuracy and false negative rate of SLNB in predicting axillary lymph node metastasis were 93.18%,83.33%,92.00%and 6.82%respectively.Six months after operation,the reduction rates of MP,C-15 and QOL score in the observation group was higher than that in control group,with significant difference (P<0.01).The incidence rate of complications in the observation group in 1 year after operation was 4.00%, which was lower than 24.00%in the control group,with significant difference(P<0.05).ConclusionSLNB can accurately predict axillary lymph node metastasis of breast cancer,guide the process of radical mastectomy and reduce surgical trauma and complications,it is worthy of clinical promotion and application.
|
|
|
|
|
[1] |
凌晨,胡旭东,张利国,等.乳腺癌根治术患者术后不同镇痛方式对细胞免疫功能及炎症介质的影响[J].广东医学,2015,36(4):551-553.
|
[3] |
山世岩,屈翔,张慧明,等.前哨淋巴结活检术在乳腺癌手术治疗中的应用[J].中国医药,2014,9(3):368-370.
|
[4] |
孙晓,丛斌斌,邱鹏飞,等.临床腋窝淋巴结阳性乳腺癌患者内乳区前哨淋巴结活检术研究[J].中国肿瘤临床,2015,42(6):341-344.
|
[5] |
朱敬军,杨金喆,张钢龄,等.前哨淋巴结活检术在早期乳腺癌手术中的应用[J].中国医药,2013,8(4):523-524.
|
[2] |
Sreekumar A,Roarty K,Rosen JM,et al.The mammary stem cell hierarchy:a looking glass into heterogeneous breast cancer landscapes[J].Endocr Relat Cancer,2015,22(6):T161-T176.
|
[6] |
王新昭,左文述,刘琪,等.2013年St Gallen乳腺癌会议国际专家共识荟萃[J].中华肿瘤防治杂志,2013,20(23):1859-1864.
|
[7] |
Ramena G,Yin Y,Yu Y,et al.CLCA2 interactor EVA1 is required for mammary epithelial cell differentiation[J].PLoS One,2016,11(3):e0147489.
|
[8] |
郑莹,吴春晓,张敏璐,等.乳腺癌在中国的流行状况和疾病特征[J].中国癌症杂志,2013,23(8):561-569.
|
[9] |
李冬霞,蔡晓燕,高建芝,等.乳腺癌组织中乳腺癌1号基因启动子甲基化状态与蛋白表达的关系[J].中国老年学杂志,2016,36(13):3195-3196.
|
[10] |
张建军.新辅助化疗联合保乳术治疗乳腺癌的临床效果分析[J].中国当代医药,2014,21(30):47-49.
|
[11] |
吴丽华,钟慕仪,高学忠,等.前哨淋巴结活检在早期乳腺癌术中替代腋窝清扫的优势[J].中国当代医药,2013,20(30):31-32,34.
|
[12] |
王海兰.乳腺癌患者行前哨淋巴结活检术与腋窝淋巴结清扫术后患侧上肢肿胀程度的调查[J].护士进修杂志,2015,30(24):2270-2272.
|
[13] |
吕艳,牛昀.乳腺癌前哨淋巴结活检假阴性原因研究新进展[J].现代肿瘤医学,2013,21(2):437-439.
|
[14] |
王子函,王岳月,滕长胜,等.乳腺癌新辅助化疗前腔镜前哨淋巴结活检术的临床应用[J].临床和实验医学杂志,2016,15(11):1108-1111.
|
[15] |
黄汉扬,石一峰,林玉玲,等.亚甲蓝染色法在乳腺癌前哨淋巴结活检术中的临床应用研究[J].中国当代医药,2013,20(20):39-40.
|
[16] |
何婕,莫钦国.前哨淋巴结活检术与腋窝淋巴结清扫术对早期乳腺癌患者生活质量的影响[J].山东医药,2014,54(2):57-59.
|
|
|
|